Presentations and Publications

people going over notesPublications

1. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment

2. Statistical analysis plan for evaluating low- vs. standard-dose alteplase in the ENhanced Control of Hypertension and Thrombolysis strokE stuDy (ENCHANTED)

3. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke

4. Statistical analysis plan for evaluating different intensities of blood pressure control in the ENhanced Control of Hypertension And Thrombolysis strokE Study

5. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial


The presentations are only to be shared with ENCHANTED investigators. Please email for the open password referring presentation you want to read, your name and institute name.

1. ENCHANTED RtPA Arm Main Results, ESOC 2016

2. Benefits and Risks of Low-Dose vs. Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy (APT), ESOC 2016

3. Efficacy of Low-dose vs Standard-dose RtPA between Asian and Non-Asian Participants with a Focus on Risk of Intracerebral Haemorrhage, ESOC 2016

4. rt-PA Dose Relevance to Older Patients, ESOC 2016

5. ENCHANTED BP Intensity Arm – Main Results, ISC 2019